|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The relationship between pain and associated characteristics of chronic ankle instability:A retrospective study显示文摘Background'. Up to 74% of people with a history of ankle sprain develop chronic ankle instability (CAI). One commonly reported residualimpairment is ankle pain;however, it has not been included in models or inclusion criteria for CAL We investigated the prevalence of pain inpeople with CAI and the association between presence of pain and other CAI characteristics.Methods'. Retrospective data from 1147 participants with CAI (age 26.6 ± 10.7 years, 59% female) were collated from previous studies that usedthe Cumberland Ankle Instability Tool as an assessment tool. Pain was assessed from Item 1 of the Cumberland Ankle Instability Tool, whichasks participants about ankle pain. Responses were divided into 3 categories: pain during daily activities, pain during moderate/vigorous physicalactivities, and no pain. The presence of pain was analyzed with descriptive statistics, the correlation between pain category and CAI characteris・tics was analyzed by /2 tests and factors associated with each pain category were analyzed by logistic regression.Results'. Among the participants, 60.1% (n = 689) reported ankle pain. Of all participants, 12.4% (n = 142) reported pain during daily activities,47.7% (n = 547) reported pain during moderate/vigorous physical activities, and 39.9% (n = 458) reported no pain. There was a strong associationbetween ankle instability and ankle pain (/2 = 122.2, p < 0.001, OR = 53& 95% confidence interval (CI): 3.84—7.53). Perceived ankle instability,age and unilateral ankle sprains were independently associated with pain (ankle instability: /2 = 43.29, p < 0.001;age: /2 = 30.37,p < 0.001;unilateral ankle sprains: /2 = 6.25, p < 0.05). There was no significant difference in the presence of pain between genders.Conclusion-. The prevalence of pain in people with CAI was high and was related to perceived ankle instability. Number of sprains, age, genderand unilateral or bilateral sprain did not modify this result except for the first pain category (pain during daily activities). There is large gap incurrent knowledge about the impact of pain in people with CAI, and this topic needs further investigation. | Saeed Al Adal Martin Mackey Fereshteh Pourkazemi Claire E.Hiller | 2020 | Journal of Sport and Health Science2020，9，1： | 8 |
| 2 | Adjuvant docetaxel for node-positive breast cancer显示文摘 | Martin M Pienkowski T Mackey G | 2005 | N Engl J Med2005，352，18： | 1 |
| 3 | TAC improves disease free survival and overall survival over FAC in node positive early breast cancer patients,BCIRG001 : 55 months follow-up 显示文摘 | Martin M Pienkowski T Mackey J | 2003 | Breast Cancer Res Treat2003，82，1： | 1 |
| 4 | Adjuvant docetaxel, doxorubi- cin,and cyclophosphamide in node -positive breast cancer: 10 - year follow - up of the phase 3 randomised BCIRG 001 trial 显示文摘 | Mackey JR Martin M Pienkowski T | 2013 | Lancet Onco12013，14，1： | 1 |
| 5 | Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node- positive breast cancer: 10-year follow- up of the phase 3 randomised BCIRG 001 trial 显示文摘 | Mackey JR Martin M Pienkowski T | 2013 | Lancet Oncol2013，14，1： | 1 |
| 6 | Adjuvant do- cetaxel for node-positive breast cancer显示文摘 | Martin M Pienkowski T Mackey J | 2005 | N Engl J Med2005，352，22： | 1 |
| 7 | Adjuvant docetaxel for node - positive breast cancer 显示文摘 | Martin M Pienkowski T Mackey J | 2005 | N Engl J Med2005，352，： | 1 |
| 8 | Adjuvant docetaxel for node-positive breast cancer显示文摘 | Martin M Pienkowski T Mackey J | 2005 | N Engl J Med2005，352，22： | 1 |
| 9 | Adjuvant docetaxel for node-positive breast cancer显示文摘 | Martin M Pienkowski T Mackey J | 2005 | New Engl J Med2005，352，： | 1 |
| 10 | Adjuvant docetaxel for node-positive breast cancer显示文摘 | Martin M Pienkowski T Mackey J | 2005 | N Engl J Med2005，352，22： | 1 |
| 11 | Adjuvant docetaxel for node-positive breast cancer显示文摘 | Martin M Pienkowski T Mackey J | 2005 | N Engl J Med2005，352，22： | 1 |
| 12 | Adjuvant docetaxel for node-positive breast cancer显示文摘 | Martin M Pienkowski T Mackey J | 2005 | N Engl J Med2005，352，22： | 1 |
| 13 | Adjuvant docetaxel for node-positive breast cancer显示文摘 | MARTIN M PIENKOWSKI T MACKEY J | 2005 | N Engl J Med2005，352，22： | 1 |
| 14 | Adjuvant docetaxel,doxorubicin, and cyclophosphamide in node-positive breast cancer~ 10-year follow-up of thephase 3 randomised BCIRG 001 trial显示文摘 | Mackey JR Martin M Pienkowski T | 2013 | Lancet Oncol2013，14，1： | 1 |
| 15 | Adjuvant docetaxel for node-positive breast cancer显示文摘 | Martin M Pienkowski T Mackey J | 2005 | N Engl J Med2005，352，22： | 1 |
| 16 | TAC improve sdiseasefree survival and over all survival over FAC in node posi tive early breast cancer patients,BCIRG001:55 months follow up 显示文摘 | Martin M Pienkowski T Mackey J | 2003 | Breast Cancer Res Treat2003，82，： | 1 |
| 17 | Adjuvant docetaxel for node-positive breast cancer显示文摘 | Martin M Pienkowski T Mackey J | 2005 | N Engl J Med2005，352，22： | 1 |
| 18 | Adjuvant docetaxel for node- positive breast cancer显示文摘 | Martin M Pienkowski T Mackey | 2005 | N Engl J Med2005，352，22： | 1 |
| 19 | TAC improves disease free survival and overall survival over FAC in node positive early breast cancer patients, BCIRG001 : 55 months follow-up显示文摘 | Martin M Pienkowski T Mackey J | 2003 | Breast Cancer Res Treat2003，82，： | 1 |
| 20 | Adjuvant docetaxel for node-positive breast cancer显示文摘 | Martin M Pienkowski T Mackey J | 2005 | N Engl J Med2005，352，22： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员